# Justin Lynch

> Justin Lynch is a Series A investor at Fountain Healthcare Partners backing Health Care. See 7 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Fountain Healthcare Partners](https://shizune.co/investors/profile/fountain-healthcare-partners)
- Location: Dublin, Ireland
- Total investments: 7
- Last investment: Feb 2026
- Lead investor: 43%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/justin-lynch-b207a224

Justin Lynch is a Series A investor at Fountain Healthcare Partners in Dublin focused on Health Care and Medical Device. Justin Lynch is based out of Dublin, Dublin and is the Partner & CFO of Fountain Healthcare Partners. Justin previously worked at NCB stockbrokers as a research analyst. Justin Lynch attended the Trinity College Dublin.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 43% |
| Medical Device | 3 | 43% |
| Medical | 1 | 14% |
| Biopharma | 1 | 14% |
| Collaboration | 1 | 14% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 43% |
| Series C | 2 | 29% |
| Series B | 1 | 14% |
| Series D | 1 | 14% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Neurent Medical | Neurent Medical is a medical device startup that develops non-surgical treatments for inflammatory sino-nasal diseases. It was founded in 2015 by Brian Shields and David Townley in Oranmore, Galway, Ireland. | $74.5M | Series C | Feb 11, 2026 |  |
| Vivasure Medical | Medical device company developing a closure device for vascular access procedures. | $23M | Series D | May 17, 2022 |  |
| Neurent Medical | Neurent Medical is a medical device startup that develops non-surgical treatments for inflammatory sino-nasal diseases. It was founded in 2015 by Brian Shields and David Townley in Oranmore, Galway, Ireland. | $11M | Series A | May 28, 2018 |  |
| Vivasure Medical | Medical device company developing a closure device for vascular access procedures. | $18.3M | Series C | Sep 08, 2016 |  |
| Neuravi | Neuravi is an early stage company in the large emerging neurointerventional device market. Led by a team experienced in endovascular device development and global commercialization, the company's initial technology platform addresses acute ischemic stroke. In collaboration with international researchers and clinicians, the company seeks todevelop new understanding that will drive innovative solutions to treat this challenging and devastating disease. Neuravi was founded in 2009 and is headquartered in Galway, Ireland, home to many of the world’s leading medical device companies. | $20.8M | Series B | Jun 17, 2015 |  |
| Neuravi | Neuravi is an early stage company in the large emerging neurointerventional device market. Led by a team experienced in endovascular device development and global commercialization, the company's initial technology platform addresses acute ischemic stroke. In collaboration with international researchers and clinicians, the company seeks todevelop new understanding that will drive innovative solutions to treat this challenging and devastating disease. Neuravi was founded in 2009 and is headquartered in Galway, Ireland, home to many of the world’s leading medical device companies. | $5.7M | Series A | Jul 11, 2012 |  |
| Vivasure Medical | Medical device company developing a closure device for vascular access procedures. | $9.9M | Series A |  |  |

7 of 7 investments shown.

## Co-investors
- [EQT Life Sciences](https://shizune.co/investors/profile/life-sciences-partners) — VC Fund, 3 deals together
- [Atlantic Bridge](https://shizune.co/investors/profile/atlantic-bridge) — VC Fund, 2 deals together
- [Delta Partners](https://shizune.co/investors/profile/delta-partners) — VC Fund, 2 deals together
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund, 2 deals together
- [Evonik Venture Capital](https://shizune.co/investors/profile/evonik-venture-capital-gmbh) — VC Fund, 2 deals together
- [Panakes Partners](https://shizune.co/investors/profile/panakes-partners) — VC Fund, 2 deals together

## About Fountain Healthcare Partners

VC Fund · Dublin, Ireland

Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.

4 contacts available at Fountain Healthcare Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Aidan King | Co-Founder & Managing Partner | https://shizune.co/investors/profile/aidan-king |
| Ena Prosser | Partner | https://shizune.co/investors/profile/ena-prosser |
| Justin Lynch | Partner & CFO | https://shizune.co/investors/profile/justin-lync |
| Manus Rogan | Co-Founder & Managing Partner | https://shizune.co/investors/profile/manus-rogan |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Justin Lynch invest in?

Justin Lynch invests primarily in Health Care, Medical Device and Medical startups, most often at Series A and Series C stage. Most of the 7 investments tracked by Shizune back companies in Ireland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Justin Lynch last invest?

The most recent investment recorded for Justin Lynch closed in Feb 2026. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co